IHC-P analysis of human lung carcinoma tissue using GTX55442 BIK (phospho Thr33) antibody. Left : Primary antibody Right : Primary antibody pre-incubated with the antigen specific peptide
IHC-P analysis of human lung carcinoma tissue using GTX55442 BIK (phospho Thr33) antibody. Left : Primary antibody Right : Primary antibody pre-incubated with the antigen specific peptide
BIK (phospho Thr33) antibody
GTX55442
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetBIK
Overview
- SupplierGeneTex
- Product NameBIK (phospho Thr33) antibody - Orthogonal Validated
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. IHC-P: 1:50-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID638
- Target nameBIK
- Target descriptionBCL2 interacting killer
- Target synonymsapoptosis inducer NBK; apoptosis-inducing NBK; bcl-2-interacting killer; BCL2-interacting killer (apoptosis-inducing); BIP1; BP4; natural born killer; NBK
- HostRabbit
- IsotypeIgG
- Protein IDQ13323
- Protein NameBcl-2-interacting killer
- Scientific DescriptionThe protein encoded by this gene shares a critical BH3 domain with other death-promoting proteins, such as BID, BAK, BAD and BAX, that is required for its pro-apoptotic activity, and for interaction with anti-apoptotic members of the BCL2 family, and viral survival-promoting proteins. Since the activity of this protein is suppressed in the presence of survival-promoting proteins, it is suggested as a likely target for anti-apoptotic proteins. [provided by RefSeq, Sep 2011]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203